Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)

• Príomhchruthaitheoirí: David Brain (Údar), James O'Beirne (Údar), Ingrid J. Hickman (Údar), Elizabeth E. Powell (Údar), Patricia C. Valery (Údar), Sanjeewa Kularatna (Údar), Ruth Tulleners (Údar), Alison Farrington (Údar), Leigh Horsfall (Údar), Adrian Barnett (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: BMC, 2020-04-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease in Australia and its recent increase mirrors the obesity and type 2 diabetes epidemics. Currently, many patients who present to primary care with abnormal liver function tests or steatosis...